Abstract
The biological activity of particles is largely dependent on their size in biological systems. Dispersion in the aqueous phase has been both a critical impediment to and a prerequisite for particle studies. Carbon black has been used as a surrogate to investigate the biological effects of carbonaceous particles. Here, biocompatible methods were established to disperse carbon black into ultrafine and fine particles which are generally distinguished by the small size of 100 nm. Carbon black with a distinct particle size, N330 and N990 were suspended in blood plasma, cell culture media, Krebs-Ringer’s solution (KR), or physiological salt solution (PSS). Large clumps were observed in all dispersion preparations; however, sonication improved dispersion - averaged particle sizes for N330 and N990 were 85.0 ± 42.9 and 112.4 ± 67.9 nm, respectively, in plasma; the corresponding sizes in culture media were 84.8 ± 38.4 and 164.1 ± 77.8 nm. However, sonication was not enough to disperse N330 less than 100 nm in either KR or PSS. Application of Tween 80 along with sonication reduced the size of N330 to less than 100 nm, and dispersed N990 larger than 100 nm (73.6 ± 28.8 and 80.1 ± 30.0 nm for N330 and 349.5 ± 161.8 and 399.8 ± 181.1 nm for N990 in KR and PSS, respectively). In contrast, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) exhibited little effect. Electron microscopy confirmed the typical aciniform structure of the carbon arrays; however, zeta potential measurement failed to explain the dispersibility of carbon black. The methods established in this study could disperse carbon black into ultrafine and fine particles, and may serve as a useful model for the study of particle toxicity, particularly size-related effects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ai, J., Biazar, E., Jafarpour, M., Montazeri, M., Majdi, A., Aminifard, S., Zafari, M., Akbari, H.R. and Rad, H.G. (2011). Nanotoxicology and nanoparticle safety in biomedical designs. Int. J. Nanomed, 6, 1117–1127.
Baan, R.A. (2007). Carcinogenic hazards from inhaled carbon black, titanium dioxide, and talc not containing asbestos or asbestiform fibers: recent evaluations by an IARC Monographs Working Group. Inhal. Toxicol., 19 Suppl 1, 213–228.
Boverhof, D.R. and David, R.M. (2010). Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation. Anal. Bioanal. Chem., 396, 953–961.
Brook, R.D., Rajagopalan, S., Pope, C.A. 3rd., Brook, J.R., Bhatnagar, A., Diez-Roux, A.V., Holguin, F., Hong, Y., Luepker, R.V., Mittleman, M.A., Peters, A., Siscovick, D., Smith, S.C. Jr., Whitsel, L. and Kaufman, J.D. (2010). Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation, 121, 2331–2378.
Castranova, V. (2011). Overview of current toxicological knowledge of engineered nanoparticles. J. Occup. Environ. Med., 53, S14–S17.
Fubini, B., Ghiazza, M. and Fenoglio, I. (2010). Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology, 4, 347–363.
Gilmour, P.S., Ziesenis, A., Morrison, E.R., Vickers, M.A., Drost, E.M., Ford, I., Karg, E., Mossa, C., Schroeppel, A., Ferron, G.A., Heyder, J., Greaves, M., Macnee, W. and Donaldson, K. (2004). Pulmonary and systemic effects of short-term inhalation exposure to ultrafine carbon black particles. Toxicol. Appl. Pharmacol., 195, 35–44.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (1996). Printing processes and printing inks, carbon black and some nitro compounds, International Agency for Research on Cancer, Geneva, pp. 1–35.
Kreyling, W.G., Semmler-Behnke, M. and Möller, W. (2006). Ultrafine particle-lung interactions: does size matter? J. Aerosol Med., 19, 74–83.
Lee, M.Y., Bae, O.N., Chung, S.M., Kang, K.T., Lee, J.Y. and Chung, J.H. (2002). Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol., 179, 83–88.
Madl, A.K. and Pinkerton, K.E. (2009). Health effects of inhaled engineered and incidental nanoparticles. Crit. Rev. Toxicol., 39, 629–658.
Morfeld, P. and Mccunney, R.J. (2010). Bayesian bias adjustments of the lung cancer SMR in a cohort of German carbon black production workers. J. Occup. Med. Toxicol., 5, 23.
Morimoto, Y., Ogami, A., Kochi, I., Uchiyama, T., Ide, R., Myojo, T. and Higashi, T. (2010). Continuing investigation of effect of toner and its by-product on human health and occupational health management of toner. Sangyo Eiseigaku Zasshi, 52, 201–208.
Nemmar, A., Hoet, P.H., Vanquickenborne, B., Dinsdale, D., Thomeer, M., Hoylaerts, M.F., Vanbilloen, H., Mortelmans, L. and Nemery, B. (2002). Passage of inhaled particles into the blood circulation in humans. Circulation, 105, 411–414.
Porter, D., Sriram, K., Wolfarth, M., Jefferson, A., Schwegler-Berry, D., Andrew, M.E. and Castranova, V. (2008). A biocompatible medium for nanoparticle dispersion. Nanotoxicology, 2, 144–154.
Sager, T.M. and Castranova, V. (2009). Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part. Fibre Toxicol., 6, 15.
Sager, T.M., Porter, D.W., Robinson, V.A., Lindsley, W.G., Schwegler-Berry, D.E. and Castranova, V. (2007). Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology, 1, 118–129.
Stone, V., Johnston, H. and Clift, M.J. (2007). Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans. Nanobiosci, 6, 331–340.
Tankersley, C.G., Campen, M., Bierman, A., Flanders, S.E., Broman, K.W. and Rabold, R. (2004). Particle effects on heart-rate regulation in senescent mice. Inhal. Toxicol., 16, 381–390.
Totlandsdal, A.I., Refsnes, M. and Låg, M. (2010). Mechanisms involved in ultrafine carbon black-induced release of IL-6 from primary rat epithelial lung cells. Toxicol. In Vitro, 24, 10–20.
Valberg, P.A., Long, C.M. and Sax, S.N. (2006). Integrating studies on carcinogenic risk of carbon black: epidemiology, animal exposures, and mechanism of action. J. Occup. Environ. Med., 48, 1291–1307.
Wang, J., Jensen, U.B., Jensen, G.V., Shipovskov, S., Balakrishnan, V.S., Otzen, D., Pedersen, J.S., Besenbacher, F. and Sutherland, D.S. (2011). Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner. Nano Lett., 11, 4985–4991.
Wang, L., Castranova, V., Mishra, A., Chen, B., Mercer, R.R., Schwegler-Berry, D. and Rojanasakul, Y. (2010). Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part. Fibre Toxicol., 7, 31.
Xia, T., Li, N. and Nel, A.E. (2009). Potential health impact of nanoparticles. Annu. Rev. Public Health, 30, 137–150.
Yang, H.M., Nam, W.K. and Park, D.W. (2007). Production of nanosized carbon black from hydrocarbon by a thermal plasma. J. Nanosci. Nanotechnol., 7, 3744–3749.
Zhang, H., Wang, Y.E., Fan, Q. and Zuo, Y.Y. (2011). On the low surface tension of lung surfactant. Langmuir, 27, 8351–8358.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://doi.org/creativecommons.org/licenses/by/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, H., Park, K. & Lee, MY. Biocompatible Dispersion Methods for Carbon Black. Toxicol Res. 28, 209–216 (2012). https://doi.org/10.5487/TR.2012.28.4.209
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2012.28.4.209